Towards a role of interleukin-32 in atherosclerosis

Cytokine

Volumn 64, Issue 1, 2013, Pages 433-440

  Heinhuis, Bas ^a   Popa, Calin D ^a   van Tits, Berry L J H ^a   Kim, Soo Hyun ^b   Zeeuwen, Patrick L ^a   van den Berg, Wim B ^a   van der Meer, Jos W M ^a   van der Vliet, J Adam ^a   Stalenhoef, Anton F H ^a   Dinarello, Charles A ^a,c   Netea, Mihai G ^a   Joosten, Leo A B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Konkuk University School of Medicine   (South Korea)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cytokines; Interleukin 32; Matrix metalloproteinases; Plaque instability; TLR ligands

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 32; INTERLEUKIN 32BETA; INTERLEUKIN 32GAMMA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UMBILICAL VEIN ENDOTHELIAL CELL;

MUS; MUS MUSCULUS;

CYTOKINES; INTERLEUKIN-32; MATRIX METALLOPROTEINASES; PLAQUE INSTABILITY; TLR-LIGANDS;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHEMOKINE CCL2; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKINS; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84883556030     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.05.002     Document Type: Article

References (30)

1. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 1999, 340:115-126.
2. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. New Engl J Med 1994, 331:417-424.
3. Solomon D.H., Kremer J., Curtis J.R., Hochberg M.C., Reed G., Tsao P., et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010, 69:1920-1925.
4. Ahmad U., Ali R., Lebastchi A.H., Qin L., Lo S.F., Yakimov A.O., et al. IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5. J Immunol 2010, 185:1283-1294.
5. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
6. Dinarello C.A. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 2006, 83:447S-455S.
7. Kamari Y., Werman-Venkert R., Shaish A., Werman A., Harari A., Gonen A., et al. Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. Atherosclerosis 2007, 195:31-38.
8. Loppnow H., Werdan K., Buerke M. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun 2008, 14:63-87.
9. Nold-Petry C.A., Nold M.F., Zepp J.A., Kim S.H., Voelkel N.F., Dinarello C.A. IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci USA 2009, 106:3883-3888.
10. Cockerill G.W., Rye K.A., Gamble J.R., Vadas M.A., Barter P.J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995, 15:1987-1994.
11. Buttice G., Miller J., Wang L., Smith B.D. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Circ Res 2006, 98:472-479.
12. O'Neill L.A., Brown Z., Ward S.G. Toll-like receptors in the spotlight. Nat Immunol 2003, 4:299.
13. Radstake T.R., Roelofs M.F., Jenniskens Y.M., Oppers-Walgreen B., van Riel P.L., Barrera P., et al. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 2004, 50:3856-3865.
14. Roelofs M.F., Joosten L.A., bdollahi-Roodsaz S., van Lieshout A.W., Sprong T., van den Hoogen F.H., et al. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005, 52:2313-2322.
15. Dinarello C.A., Kim S.H. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006, 65:iii61-iii64.
16. Kim S.H., Han S.Y., Azam T., Yoon D.Y., Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22:131-142.
17. Netea M.G., Azam T., Ferwerda G., Girardin S.E., Walsh M., Park J.S., et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005, 102:16309-16314.
18. Heinhuis B., Koenders M.I., van de Loo F.A., van Lent P.L., Kim S.H., Dinarello C.A., et al. IL-32{gamma} and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2. Ann Rheum Dis 2010, 69:1866-1872.
19. Heinhuis B., Koenders M.I., van Riel P.L., van de Loo F.A., Dinarello C.A., Netea M.G., et al. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis 2010, 70:660-667.
20. Joosten L.A., Netea M.G., Kim S.H., Yoon D.Y., Oppers-Walgreen B., Radstake T.R., et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006, 103:3298-3303.
21. Choi J., Bae S., Hong J., Ryoo S., Jhun H., Hong K., et al. Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis. Proc Natl Acad Sci USA 2010, 107:21082-21086.
22. Waldo S.W., Li Y., Buono C., Zhao B., Billings E.M., Chang J., et al. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol 2008, 172:1112-1126.
23. Heinhuis B., Koenders M.I., van de Loo F.A., Netea M.G., van den Berg W.B., Joosten L.A. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc Natl Acad Sci USA 2011, 108:4962-4967.
24. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
25. van Tits L.J., Stienstra R., van Lent P.L., Netea M.G., Joosten L.A., Stalenhoef A.F. Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Kruppel-like factor 2. Atherosclerosis 2011, 214:345-349.
26. Gough P.J., Gomez I.G., Wille P.T., Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 2006, 116:59-69.
27. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998, 187:601-608.
28. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001, 107:1255-1262.
29. Ramos C.L., Huo Y., Jung U., Ghosh S., Manka D.R., Sarembock I.J., et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 1999, 84:1237-1244.
30. Kobayashi H., Huang J., Ye F., Shyr Y., Blackwell T.S., Lin P.C. Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS ONE 2010, 5:e9458.